# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Baird analyst Catherine Ramsey maintains Natera (NASDAQ:NTRA) with a Outperform and raises the price target from $99 to $117.
U.S. stocks are on track to finish the week on a high, with the index futures pointing to a higher opening on Friday.
Natera (NASDAQ:NTRA) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.71) by 21....
Expanded EBLIS study with up to 12 years of clinical follow-up across all subtypes of breast cancer
-Bloomberg